Archive
Search
Journal Information
Online ISSN
1305-3124
Established
1993
Editors-in-Chief
Cihat Şen, Nicola Volpe
Editors
Cecilia Villalain, Daniel Rolnik, M. Mar Gil
Managing Editors
Murat Yayla
Statistics Editor
Resul Arısoy
Article info
. Perinatal Journal 2005;13(Suppl):s133-137
Author(s) Information
- Gazi Üniversitesi Tıp Fakültesi, Tıbbi Biyoloji ve Genetik Anabilim Dalı- Ankara TR
Correspondence
Ali Ergün, Gazi Üniversitesi Tıp Fakültesi, Tıbbi Biyoloji ve Genetik Anabilim Dalı- Ankara TR, [email protected]
Publication History
Conflicts of Interest
No conflicts declared.
Keywords
1. Enkin M, Keirse MJNC, Neilson J, Crowther C, Duley LMM, Hodnett E, et al. Guide to Effective Care in Pregnancy and Childbirth. 3rd ed. Oxford: Oxford University Press; 2000.
2. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94:869–77.
3. Smith GN, Walker MC, McGrath MJ. Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br J Obstet Gynaecol 1999;106:736–9.
4. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173–83.
5. Hannah ME. Search for best tocolytic for preterm labour. Lancet 2000;356:699–700.
6. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus betaadrenergic agonists in the treatment of preterm labour. BJOG 2001;108:133–42.
7. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191–9.
8. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177–85.
9. Oei SG, Mol BW, de Kleine MJ, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999;78:783–8.
10. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001;97:840–7.
11. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour Cochrane Database Syst Rev 2002;(3).
12. Harake B, Gilbert RD, Ashwal S, Power GG. Nifedipine: effects on fetal and maternal haemodynamics in pregnant sheep. Am J Obstet Gynecol 1987;157:1003–8.
13. Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev 2002;(3). 14. Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 1989;74:567–72.
15. Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991;164:981–6.
16. Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol 1991;78:1093–7.
17. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 1991;164:141–6.
18. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602–7.
19. Formulary pack. Ferring Pharmaceuticals Ltd, June 2000.
20. British National Formulary website: http://bnf.vhn.net/home. Last accessed 27 August 2001.
21. Papatsonis DN, van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:230–4.
22. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labor: a meta-analysis. Obstet Gynecol 1995;85:313–7.
23. Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2001;(1).
24. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol 1999;181:484–90.
25. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000;182:1184–90.
2. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94:869–77.
3. Smith GN, Walker MC, McGrath MJ. Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br J Obstet Gynaecol 1999;106:736–9.
4. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173–83.
5. Hannah ME. Search for best tocolytic for preterm labour. Lancet 2000;356:699–700.
6. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus betaadrenergic agonists in the treatment of preterm labour. BJOG 2001;108:133–42.
7. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191–9.
8. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177–85.
9. Oei SG, Mol BW, de Kleine MJ, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999;78:783–8.
10. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001;97:840–7.
11. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour Cochrane Database Syst Rev 2002;(3).
12. Harake B, Gilbert RD, Ashwal S, Power GG. Nifedipine: effects on fetal and maternal haemodynamics in pregnant sheep. Am J Obstet Gynecol 1987;157:1003–8.
13. Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev 2002;(3). 14. Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 1989;74:567–72.
15. Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991;164:981–6.
16. Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol 1991;78:1093–7.
17. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 1991;164:141–6.
18. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602–7.
19. Formulary pack. Ferring Pharmaceuticals Ltd, June 2000.
20. British National Formulary website: http://bnf.vhn.net/home. Last accessed 27 August 2001.
21. Papatsonis DN, van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:230–4.
22. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labor: a meta-analysis. Obstet Gynecol 1995;85:313–7.
23. Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2001;(1).
24. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol 1999;181:484–90.
25. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000;182:1184–90.